Lecanemab (Mouse IgG2a) is a monoclonal antibody engineered to target soluble ??-amyloid, a key player in the pathogenesis of Alzheimer's disease. This antibody is designed to mitigate cognitive decline by interacting with ??-amyloid peptides. The variable region of Lecanemab (Mouse IgG2a) mirrors that of the original Lecanemab, ensuring specificity and efficacy in targeting, while its constant region is derived from the Mouse IgG2a sequence, facilitating its use in various experimental setups. Lecanemab (Mouse IgG2a) is an invaluable tool for advancing Alzheimer's disease research, offering potential insights into disease mechanisms and therapeutic interventions.
Lecanemab (Mouse IgG2a) is a monoclonal antibody engineered to target soluble ??-amyloid, a key player in the pathogenesis of Alzheimer's disease. This antibody is designed to mitigate cognitive decline by interacting with ??-amyloid peptides. The variable region of Lecanemab (Mouse IgG2a) mirrors that of the original Lecanemab, ensuring specificity and efficacy in targeting, while its constant region is derived from the Mouse IgG2a sequence, facilitating its use in various experimental setups. Lecanemab (Mouse IgG2a) is an invaluable tool for advancing Alzheimer's disease research, offering potential insights into disease mechanisms and therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
